Sopharma AD (BUL: SFA)

Bulgaria flag Bulgaria · Delayed Price · Currency is BGN
5.70
0.00 (0.00%)
At close: Dec 2, 2024
-19.72%
Market Cap 944.66M
Revenue (ttm) 2.05B
Net Income (ttm) 81.91M
Shares Out 165.73M
EPS (ttm) 0.46
PE Ratio 12.32
Forward PE n/a
Dividend 0.15 (2.63%)
Ex-Dividend Date Nov 7, 2024
Volume 50,700
Open n/a
Previous Close n/a
Day's Range n/a
52-Week Range 5.56 - 7.14
Beta n/a
Analysts n/a
Price Target n/a
Earnings Date Jan 30, 2025

About Sopharma AD

Sopharma AD produces, distributes, and exports pharmaceutical products in Europe, Bulgaria, and internationally. The company operates through Production of Pharmaceutical Products; Distribution of Pharmaceutical Products (Goods); and Others. It offers Carsil to treat liver disease; Tempalgin and Analgin, a painkiller; Tabex, drug used for smoking secession; Tribestan, drug used for stimulation of the male reproductive system; Broncholytin, which is used to suppress cough; Nivalin, used for diseases of the peripheral nervous system; Methylpredni... [Read more]

Industry Pharmaceutical Preparations
Founded 1933
Employees 4,721
Stock Exchange Bulgarian Stock Exchange
Ticker Symbol SFA
Full Company Profile

Financial Performance

In 2023, Sopharma AD's revenue was 1.89 billion, an increase of 12.95% compared to the previous year's 1.67 billion. Earnings were 95.21 million, an increase of 33.87%.

Financial Statements

News

There is no news available yet.